Related Experiment Video
Updated: Oct 7, 2025

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web
Published on: July 16, 2017
Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations.
Liadys Mora Lagares1,2, Yunierkis Pérez-Castillo3, Nikola Minovski1
1Theory Department, Laboratory for Cheminformatics, National Institute of Chemistry, 1000 Ljubljana, Slovenia.
Molecular dynamics simulations reveal how P-glycoprotein (P-gp) changes shape when drugs bind. Understanding these interactions is key to overcoming multidrug resistance (MDR) in cancer and antiviral therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- P-glycoprotein (P-gp) is an efflux pump limiting intracellular drug accumulation.
- P-gp contributes to multidrug resistance (MDR), hindering cancer and antiviral therapies.
- Understanding ligand-P-gp interactions is crucial for drug development and toxicity prediction.
Purpose of the Study:
- Investigate the effects of compound binding on P-gp conformational dynamics.
- Correlate ligand interactions with P-gp conformational changes and activation of translocation.
- Validate simulation methods against experimental data and binding-free energy estimations.
Main Methods:
- Performed molecular dynamics (MD) simulations of human P-gp (hP-gp).
- Simulated hP-gp in an explicit membrane-and-water environment.
- Analyzed conformational dynamics upon binding of different compounds.
Main Results:
- Observed significant differences in P-gp behavior with active versus non-active compounds.
- Identified distinct movement patterns correlating with conformational changes and translocation activation.
- Predicted ligand-P-gp interactions align well with experimental data and binding-free energy calculations.
Conclusions:
- MD simulations provide insights into ligand-induced conformational changes in P-gp.
- The findings support the development of strategies to overcome MDR.
- The study validates the use of MD simulations for predicting P-gp-ligand interactions and guiding drug design.
More Related Videos
Related Concept Videos
Protein Organization
The primary structure of a protein is its amino acid sequence....
ABC Transporters: Exporter
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

